Second-generation antipsychotics for major depressive disorder and dysthymia-Reference-Cited by-同舟云学术

Second-generation antipsychotics for major depressive disorder and dysthymia

Published:2010-12-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Komossa Katja¹,Depping Anna M¹,Gaudchau Andrea¹,Kissling Werner¹,Leucht Stefan¹

Affiliation:

1. Technische Universität München Klinikum rechts der Isar; Klinik und Poliklinik für Psychiatrie und Psychotherapie; Moehlstrasse 26 München Germany 81675

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD008121.pub2/fullpdf

Reference110 articles.

1. Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study;Amore;International Clinical Psychopharmacology,2001

2. Bauer M Pretorius H Earley W Lindgren P Brecher M Results from a phase III study of extended release quetiapine fumarate (quetiapine XR) as add-on to antidepressants in patients with major depressive disorder (MDD) 7th International Forum on Mood and Anxiety Disorders 2007

3. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study;Berman;Journal of Clinical Psychiatry,2007

4. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants;Berman;CNS Spectrums,2009

5. Atypical antipsychotic drugs in dysthymia: placebo controlled studies of amisulpride versus imipramine, versus amineptine;Boyer;European Psychiatry,1996

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the antidepressant effect of ketamine separate from its psychotomimetic effect? A review of rodent models;Neuropharmacology;2024-11

2. Prioritization of Psychopathological Symptoms and Clinical Characterization in Psychiatric Diagnoses;JAMA Psychiatry;2024-09-11

3. Application of GWAS summary data and drug-induced gene expression profiles of neural progenitor cells in psychiatric drug prioritization analysis;Molecular Psychiatry;2024-07-13

4. Efficacy and safety of low-dose amisulpride versus olanzapine-fluoxetine combination in post-schizophrenic depression: A randomized controlled trial;Journal of Psychiatric Research;2024-05

5. A Canadian Simulation Model for Major Depressive Disorder: Study Protocol;PharmacoEconomics - Open;2024-03-26